David Goldberg

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

Natasha K. Martin, Peter Vickerman, Jason Grebely et al. · Hepatology · 2013 · 502 citations · Full text

Pharmacy, Infectious Disease Control, Pharmacotherapy +15

Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study

Anoop Shah, Rachael Wood, Ciara Gribben et al. · BMJ · 2020 · 380 citations · Full text

Public Health, Health Sciences, Infectious Diseases +17

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy

Natasha K. Martin, Matthew Hickman, Sharon Hutchinson et al. · Clinical Infectious Diseases · 2013 · 320 citations · Full text

Public Health, Infectious Disease Control, Preventive Medicine +16

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility

Natasha K. Martin, Peter Vickerman, Graham R. Foster et al. · Journal of Hepatology · 2010 · 231 citations

Pharmacy, Infectious Disease Control, Pharmacotherapy +14

Cost–Effectiveness of Hepatitis C Virus Antiviral Treatment for Injection Drug User Populations

Natasha K. Martin, Peter Vickerman, Alec Miners et al. · Hepatology · 2011 · 223 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17